Overview

A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

Status:
COMPLETED
Trial end date:
2024-09-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of KH001 in patients with dentin hypersensitivity.
Phase:
PHASE2
Details
Lead Sponsor:
HysensBio Co., Ltd